¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦ 1Â÷ ´ëÇÑ¿©µå¸§ÁÖ»çÇÐȸ ±³À° ½ÉÆ÷Áö¿ò (1st annual Korean Acne and Rosacea Scientific Insight Symposium) : 2023-03-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦ 1Â÷ ´ëÇÑ¿©µå¸§ÁÖ»çÇÐȸ ±³À° ½ÉÆ÷Áö¿ò (1st annual Korean Acne and Rosacea Scientific Insight Symposium) : 2023-03-11
±³À°ÀÏÀÚ : 2023-03-11
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø ÁöÇÏ 1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : Á¦ 1Â÷ ´ëÇÑ¿©µå¸§ÁÖ»çÇÐȸ ±³À° ½ÉÆ÷Áö¿ò (1st annual Korean Acne and Rosacea Scientific Insight Symposium)
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿©µå¸§ÁÖ»çÇÐȸ  
´ã´çÀÚ : °íÁÖ¿¬ ±³¼ö
¿¬¶ôó : 02-2290-8441  
À̸ÞÀÏ : drko0303@hanyang.ac.kr      
±³À°Á¾·ù : ÇǺΰú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 500,000¿ø      
ºñ°í ´ëÇÑÇǺΰúÇÐȸ ȸ¿ø(ÇǺΰú Àü°øÀÇ Æ÷ÇÔ): ¹«·á /ºñȸ¿ø: 50¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 13:00~13:30 Looking through acne comorbidities  ½Å¹Î°æ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 13:30~14:00 Prevalence and management of acne in atopic dermatitis patients  ±èÇý¼º(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 14:00~14:30 Prevalence and management of acne and rosacea in psoriasis patients  ±èÁ¤Àº(¼øõÇâÀÇ´ë) 
È޽Ġ03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 14:30~14:50   () 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 14:50~15:20 Recent advances in understanding of rosacea  ÃÖÈÆ(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 15:20~15:50 Advances in the treatment of rosacea  ÃÖÀ¯¼º(¼øõÇâÀÇ´ë) 
È޽Ġ03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 15:50~16:10   () 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 16:10~16:40 Recent advances in understanding of hidradenitis suppurativa (HS)  ÀÌ¿µº¹(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 16:40~17:10 HS: Adalimumab clinical study data and post marketing surveillance  ÀÌÈñÁ¤(Â÷ÀÇ´ë) 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 17:10~17:40 HS: Secukinumab clinical study data and potential new drugs  ¹Ú±Í¿µ(Áß¾ÓÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦ 1Â÷ ´ëÇÑ¿©µå¸§ÁÖ»çÇÐȸ ±³À° ½ÉÆ÷Áö¿ò (1st annual Korean Acne and Rosacea Scientific Insight Symposium) : 2023-03-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023 ÀüºÏ³»°úÀÇ»çȸ Çмú´ëȸ : 2023-03-11
´ÙÀ½±Û ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 2023 8th Busan Shoulder and Elbow Symposium (Inje University Haeundae Paik Hospital) : 2023-03-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20820 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ – Á¦31ȸ °³¿øÀǸ¦ À§ÇÑ ¿¬¼ö°­Á : 2024-06-16 0 6 2024-05-27
20819 ºÎ»ê ´ëÇÑÀ̽ÄÇÐȸ 2024³â ½ÅÀåÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-16 0 7 2024-05-27
20818 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-16 0 10 2024-05-27
20817 ¼­¿ï ¼Ò¾Æû¼Ò³âÇൿ¹ß´ÞÁõÁø ¾ð¾î°Ë»ç ÇÁ·Î±×·¥ ¿öÅ©¼ó : 2024-06-16 0 6 2024-05-27
20816 ¼­¿ï Á¦28ȸ ¼­¿ï½Ã³»°úÀÇ»çȸ Á¤±âÃÑȸ ¹× Çмú´ëȸ : 2024-06-16 0 19 2024-05-27
20815 ¼­¿ï 2024³â Á¦16ȸ °æÈñ´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-16 0 21 2024-05-27
20814 ºÎ»ê 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿µ³²¼Ò¾Æ¾Ë·¹¸£±â ½ÉÆ÷Áö¿ò : 2024-06-16 0 8 2024-05-27
20813 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦23Â÷ ½Å»ý¾Æ¼Ò»ý¼ú workshop : 2024-06-16 0 24 2024-05-27
20812 ¼­¿ï 2024³â ´ëÇÑÀÇÇÐÀ¯ÀüÇÐȸ ÀÇÇÐÀ¯ÀüÇÐ Primer Course : 2024-06-16 0 40 2024-05-27
20811 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 41 2024-05-27
20810 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°ú ÄÄÇ»Åͼö¼úÇÐȸ - Á¦3ȸ ±¹Á¦ ·Îº¿¼ö¼ú ½ÉÆ÷Áö¾ö : 2024-06-15 0 7 2024-05-27
20809 °æ±â ´ëÇѺñ¸¸ÇÐȸ Á¦18ȸ ODOT (One Day Course of Obesity Treatment) : 2024-06-15 0 8 2024-05-27
20808 ¼­¿ï 2024³â Á¦ 1ȸ ºñ¸¸ ¿¬¼ö°­ÁÂ(ObesityCare Pro) : 2024-06-15 0 6 2024-05-27
20807 ¼­¿ï 2024 °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ½Å°æ¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20806 ¼­¿ï ´ëÇѼöºÎ¿Ü°úÇÐȸ ¼öºÎ»óÁö ÇÏ°èÇмú´ëȸ : 2024-06-15 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷